Tag: press release

New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced the pricing of its initial public offering (the “Offering”) of 2,666,667 ordinary shares (the “Ordinary Shares”) at a public offering price of $7.50 per share. The Company expects to receive aggregate gross proceeds of approximately $20 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on June 17, 2025 under the ticker symbol “MENS”. The Offering is expected to close on June 18, 2025, subject to the satisfaction of customary closing conditions. In addition, the Company has granted the underwriters an option (the "Over-Allotment Option"), within 45 days from the date of the final prospectus, to purchase up to an additional 400,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover the Over-Allotment Option, if any.

Monterey, CA, June 16, 2025 (GLOBE NEWSWIRE) -- ChampionsGate Acquisition Corporation (the “Company”) (Nasdaq: CHPGU), a blank check company, today announced that, commencing on June 20, 2025, holders of the 7,475,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”) including Units sold upon a full exercise of the underwriters’ over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “CHPGU.” Any underlying Class A ordinary shares and rights that are separated will trade on the NASDAQ under the symbols “CHPG” and “CHPGR,” respectively. Holders of Units will need to have their brokers contact the Company’s transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders’ Units into Class A ordinary shares and rights.

QUEBEC CITY, Canada, June 16, 2025 (GLOBE NEWSWIRE) -- LeddarTech^® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous driving (AD), today announces that, further to its press release dated June 11, 2025, it intends on making an assignment into bankruptcy pursuant to the Bankruptcy and Insolvency Act (Canada) (the “BIA”).

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s investors under the federal securities laws.

Innovative technological leader to oversee all technical, operational, customer support and business development initiatives

Dubai, UAE , June 16, 2025 (GLOBE NEWSWIRE) -- In a major leap toward redefining privacy in Web3, NullTrace officially announces the upcoming launch of its OTC marketplace (Phase 1 of Shadow DEX), AI dapp assistant & native privacy wallet, solidifying its position as the go-to privacy layer on Solana. As blockchain adoption grows and transparency becomes a double-edged sword, on-chain privacy is no longer optional—it’s critical infrastructure.

NullTrace offers a ZK-powered, full-stack privacy suite: stealth swaps, token mixers, private transfers and airdrops, and an untraceable cross-chain bridge. Its tools empower users with confidential custody, anonymous transfers, and unlinkable activity—all while maintaining decentralization and performance.

Privacy Without Compromise

Blockchain transparency has made wallet activity, trades, and airdrops fully public. This deters institutional adoption and exposes users to surveillance. NullTrace fixes this with stealth address infrastructure, encrypted balances, and zero-knowledge proofs—all native to Solana.

Key Offerings Include:

ZK Privacy Bridge: Enables unlinkable cross-chain value movement using stealth routing.

SPL Mixer: Native Solana mixer supporting SOL & SPL tokens, enabling encrypted transfers.

Privacy Airdrops: Distribute tokens to stealth addresses with zero exposure.

$NULL Token: Access tools, earn revshare, and participate in governance.

Protocol fees are shared with $NULL holders and partially burned, creating strong utility and alignment with growth.

What’s Coming Next

This announcement comes as NullTrace prepares to roll out two major privacy innovations:

Shadow DEX: A stealth orderbook DEX with encrypted matching and on-chain private settlement—ideal for OTC deals and DAO allocations.

Null Wallet: A fully integrated wallet optimized for stealth address management and shielded asset tracking.

AI Chat Assistant: Built into both web and Telegram interfaces, this guide helps users navigate complex privacy tools and protocols seamlessly.

Live Today

- SPL Mixer (SOL & tokens)

- Private Bridge (Solana-native)

- Stealth Airdrop Tool

- Revenue Sharing via $NULL

Coming in 2025

- Shadow DEX Phase 1

- Full AI Assistant Rollout

- Launch of Null Wallet

- EVM & Bitcoin Support

Final Word

NullTrace isn’t just building a mixer—it’s constructing the privacy foundation of Solana and Web3. With the upcoming launch of its privacy-native wallet and Shadow DEX, the protocol is delivering programmable, high-speed, trustless confidentiality to everyone—from retail users to DAOs and institutions.

Explore NullTrace:

Web App: https://nulltrace.xyz/

Docs: https://docs.nulltrace.xyz/

Twitter/X: https://x.com/nulltracebot

All Links: https://linktr.ee/nulltrace

Privacy isn’t a luxury. It’s infrastructure—and NullTrace is making it mainstream.

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

PETACH TIKVA, Israel, June 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that following its recently announced successful SHIELD II phase 3 topline results, it has secured additional funding through the exercise of warrants with aggregate gross proceeds of $26.7 million. The Company anticipates that with this additional funding, PolyPid’s runway would be extended beyond anticipated FDA approval of D-PLEX₁₀₀.